| (USD) | Dec 2023 | Q/Q |
|---|---|---|
| Revenue | 59.4MM | -13% |
| Gross Profit | 28.2MM | -17% |
| Cost Of Revenue | 39.9MM | -6% |
| Operating Income | -29MM | -38% |
| Operating Expenses | 57.1MM | -29% |
| Net Income | -26.6MM | -42% |
| R&D | 6.7MM | +50% |
| G&A | 24.8MM | +46% |
| Marketing | 25.7MM | -2% |
| Amortization | 4.2MM | -4% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
GOLETA, Calif., April 10, 2024--Inogen to Report First Quarter 2024 Financial Results on May 7, 2024
Inogen (INGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Expanding product portfolio and high prospects for POC raise optimism for Inogen (INGN) stock.
GOLETA, Calif., March 25, 2024--Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference
GOLETA, Calif., March 07, 2024--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that, effective March 4, 2024, the Compensation Committee of Inogen’s Board of Directors approved awards of restricted stock units as material inducement to Michael Bourque entering into employment with the company to serve as its Executive Vice President, Chief Financial Officer and Treasurer. The equity awards were a
Inogen ( NASDAQ:INGN ) Full Year 2023 Results Key Financial Results Revenue: US$315.7m (down 16% from FY 2022). Net...
Inogen, Inc. (NASDAQ:INGN) Q4 2023 Earnings Call Transcript February 27, 2024 Inogen, Inc. misses on earnings expectations. Reported EPS is $-1.14 EPS, expectations were $-0.65. Inogen, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and welcome to the […]
Inogen's (INGN) fourth-quarter earnings and revenues miss their respective consensus estimate. Gross margin expands while the company continues to incur losses at the operating level.
Q4 2023 Inogen Inc Earnings Call
While the top- and bottom-line numbers for Inogen (INGN) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.